Nicotine replacement therapy use among a cohort of smokers.
- Authors
- Alberg, Anthony J; Patnaik, Jennifer L; May, Joseph W; Hoffman, Sandra C; Gitchell, Joe; Comstock, George W; Helzlsouer, Kathy J
- Year
- 2005
- Journal
- Journal of addictive diseases
- PMID
- 15774414
- DOI
- 10.1300/J069v24n01_09
BACKGROUND: Nicotine replacement therapy (NRT) has been shown to assist smokers to stop smoking in randomized trials, but little is known about its use in the general population. METHODS: As part of ongoing follow-up of a cohort established in 1989 in Washington County, Maryland, a questionnaire mailed in 1998 included a question about ever use of the two NRT products then available over-the-counter: nicotine gum and nicotine patch. This study reports on ever use of NRT among the 1,954 respondents who were current smokers in 1989 and subsequently provided data on NRT use and smoking habits in 1998. RESULTS: Overall, 36% of the smokers in 1989 had ever used NRT in some form by 1998; 10% used gum only, 16% used patch only, and 10% used both gum and patch. Number of cigarettes smoked per day at baseline was the strongest predictor of ever use of NRT (ptrend < 0.001). Compared to nonusers, ever users of NRT were more likely to have more than 12 years of education (p < 0.01) and be 25-54 years old at baseline (p < 0.001). When NRT use was assessed in relation to smoking status in 1998, 30% of NRT ever users compared to 39% of nonusers had quit smoking (p < 0.01). Among persistent smokers, the likelihood of reducing the number of cigarettes smoked per day was similar between NRT ever users (40%) and nonusers (41%). CONCLUSIONS: Ever use of NRT was common among this cohort of smokers, particularly among heavy smokers. Compared to nonusers, ever users of NRT were less likely to have stopped smoking and equally likely to cut down the frequency of smoking. This may reflect a tendency to turn to NRT for help after failing to quit by other means.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. | 2012 | 22648373 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| E-Cigarette Use and Use of Evidence-Based Smoking Cessation Methods Among American Indian Cigarette Smokers: A Cross-Sectional Analysis. | Comiford AL et al. | — | 2025 | → |
| Smokers' utilization of quitting methods and vaping during pregnancy: an empirical cluster analysis of 2016-2018 Pregnancy Risk Assessment Monitoring System (PRAMS) data in seven US states. | Wang X et al. | — | 2023 | → |
| Evaluating level of adherence to nicotine replacement therapy and its impact on smoking cessation: a protocol for systematic review and meta-analysis. | Mersha AG et al. | — | 2020 | → |
| Potential for non-combustible nicotine products to reduce socioeconomic inequalities in smoking: a systematic review and synthesis of best available evidence. | Lucherini M et al. | — | 2019 | → |
| Effectiveness of Pharmaceutical Smoking Cessation Aids in a Nationally Representative Cohort of American Smokers. | Leas EC et al. | — | 2018 | → |
| Factors associated with nicotine replacement therapy use among hospitalised smokers. | Chui CY et al. | — | 2018 | → |
| How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor. | Villanti AC et al. | — | 2018 | → |
| Mailed distribution of free nicotine patches without behavioral support: Predictors of use and cessation. | Kushnir V et al. | — | 2017 | → |
| Overview of Electronic Nicotine Delivery Systems: A Systematic Review. | Glasser AM et al. | — | 2017 | → |
| Impact of self-reported lifetime depression or anxiety on effectiveness of mass distribution of nicotine patches. | Kushnir V et al. | — | 2016 | → |
| Telephone Smoking-Cessation Counseling for Smokers in Mental Health Clinics: A Patient-Randomized Controlled Trial. | Rogers ES et al. | — | 2016 | → |
| Association between duration of use of pharmacotherapy and smoking cessation: findings from a national survey. | Siahpush M et al. | — | 2015 | → |
| Duration of nicotine replacement therapy use and smoking cessation: a population-based longitudinal study. | Zhang B et al. | — | 2015 | → |
| Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. | West R et al. | — | 2015 | → |
| Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. | Dhalwani NN et al. | — | 2015 | → |
| A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. | Raupach T et al. | — | 2014 | → |
| Effectiveness of proactive and reactive services at the Swedish National Tobacco Quitline in a randomized trial. | Nohlert E et al. | — | 2014 | → |
| Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. | Kasza KA et al. | — | 2013 | → |
| Long-term follow-up of a high- and a low-intensity smoking cessation intervention in a dental setting--a randomized trial. | Nohlert E et al. | — | 2013 | → |
| Mind-body practices: an alternative, drug-free treatment for smoking cessation? A systematic review of the literature. | Carim-Todd L et al. | — | 2013 | → |
| Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. | Chen LS et al. | — | 2012 | → |
| Support for smoke-free policy, and awareness of tobacco health effects and use of smoking cessation therapy in a developing country. | Owusu-Dabo E et al. | — | 2011 | → |
| Use and perceived helpfulness of smoking cessation methods: results from a population survey of recent quitters. | Hung WT et al. | — | 2011 | → |
| Interest in treatments to stop smoking. | Hughes JR et al. | — | 2009 | → |
| Maine's Tobacco Medication Program: compliance, patterns of use, and satisfaction among smokers. | Tworek C et al. | — | 2009 | → |
| Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy. | Henningfield JE et al. | — | 2009 | → |
| New insights into the sympathetic, endothelial and coronary effects of nicotine. | Adamopoulos D et al. | — | 2008 | → |
| Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness. | Walsh RA | — | 2008 | → |
| Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. | Fu SS et al. | — | 2008 | → |
| Use of smoking-cessation treatments in the United States. | Shiffman S et al. | — | 2008 | → |
| Pharmacological approaches to smoking cessation. | Mitrouska I et al. | — | 2007 | → |
| Complementary treatments for tobacco cessation: a survey. | Sood A et al. | — | 2006 | → |